U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
182941182941Effect of Symbicort on GR Localisation in AsthmaCompletedNo Results AvailableAsthmaProcedure: Induced Sputum|Drug: Symbicort, Formoterol, Budesonide and Placebohttps://ClinicalTrials.gov/show/NCT00159263
182942182942Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular DystrophyCompletedNo Results AvailableDuchenne Muscular DystrophyDrug: AVI-4658 (PMO)https://ClinicalTrials.gov/show/NCT00159250
182943182943GR Defect in Peripheral Blood Mononuclear Cells in COPDCompletedNo Results AvailableChronic Obstructive Pulmonary DiseaseProcedure: blood testhttps://ClinicalTrials.gov/show/NCT00159237
182944182944Induction-maintenance of Lopinavir/r in HIV-infected SubjectsCompletedNo Results AvailableHIV InfectionsDrug: Lopinavir/ritonavir simplification strategyhttps://ClinicalTrials.gov/show/NCT00159224
182945182945Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or InsulinTerminatedNo Results AvailableType 2 DiabetesDrug: UMULINE NPH|Drug: pioglitazonehttps://ClinicalTrials.gov/show/NCT00159211
182946182946Amyotrophic Lateral Sclerosis and Frontotemporal DementiaTerminatedNo Results AvailableFrontotemporal Dementia|Amyotrophic Lateral Sclerosishttps://ClinicalTrials.gov/show/NCT00159198
182947182947Epidemiology Study in Major Orthopaedic SurgeryCompletedNo Results AvailableThrombosis|Postoperative Complications|Quality of Lifehttps://ClinicalTrials.gov/show/NCT00159185
182948182948Safety and Efficacy of Motor Cortex Stimulation in the Treatment of Advanced Parkinson DiseaseRecruitingNo Results AvailableParkinson DiseaseDevice: Motor cortex stimulationhttps://ClinicalTrials.gov/show/NCT00159172
182949182949LOW CYCLO: Study Evaluating the Benefit of Two Doses of Ciclosporine in de Novo Cardiac TransplantActive, not recruitingNo Results AvailableCardiac TransplantionDrug: Ciclosporine 130 µg/l - https://ClinicalTrials.gov/show/NCT00159159
182950182950Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major DepressionTerminatedNo Results AvailableMajor DepressionDrug: Pindolol and venlafaxinhttps://ClinicalTrials.gov/show/NCT00159146
182951182951Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode SchizophreniaCompletedNo Results AvailableSchizophrenia|PsychosesDrug: antipsychotics vs. Lorazepam (Drugs)https://ClinicalTrials.gov/show/NCT00159133
182952182952Maintenance Treatment vs. Stepwise Drug Discontinuation in First-Episode SchizophreniaCompletedNo Results AvailableSchizophrenia|PsychosesOther: maintained antipsychotic treatment vs. stepwise drug discontinuationhttps://ClinicalTrials.gov/show/NCT00159120
182953182953Integrative Therapy in AlcoholismCompletedNo Results AvailableAlcoholismDrug: Acamprosate|Behavioral: Integrative behavior therapy|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00159107
182954182954A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast CancerRecruitingNo Results AvailableMetastatic Breast CancerDrug: Doxil and Vinorelbinehttps://ClinicalTrials.gov/show/NCT00159094
182955182955One Year Drug Treatment in First-Episode SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: Haloperidol, Risperidone (drug)https://ClinicalTrials.gov/show/NCT00159081
182956182956Analysis of Genetic Factors Which May Influence the Course of HIV InfectionCompletedNo Results AvailableHIV Infectionhttps://ClinicalTrials.gov/show/NCT00159068
182957182957Adoptive Immunotherapy for CMV DiseaseWithdrawnNo Results AvailableCMV DiseaseBiological: CMV vaccinehttps://ClinicalTrials.gov/show/NCT00159055
182958182958Genetic Factors Affecting the Severity of Beta ThalassemiaRecruitingNo Results AvailableBeta Thalassemiahttps://ClinicalTrials.gov/show/NCT00159042
182959182959Genetics of Alpha Thalassemia in Israeli Ethnic GroupsRecruitingNo Results AvailableAlpha Thalassemiahttps://ClinicalTrials.gov/show/NCT00159029
182960182960Role of Glivec in Patients With Tumor Cells Positive for C-kit or PDGFR; a Multi Center Study.WithdrawnNo Results AvailableMetastatic Solid Tumors.Drug: Glivechttps://ClinicalTrials.gov/show/NCT00159016
182961182961Analysis of Genetic Factors Related to Predisposition and Prognosis of Hematological Malignancies in IsraelRecruitingNo Results AvailableAcute Myeloid Leukemia|Chronic Lymphocytic Leukemia|Chronic Myelogenous Leukemiahttps://ClinicalTrials.gov/show/NCT00159003
182962182962Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression.CompletedNo Results AvailableMajor Depression|Bipolar Disorder|Unipolar DepressionDrug: triiodothyronine|Drug: sertralinehttps://ClinicalTrials.gov/show/NCT00158990
182963182963CONTAK RENEWAL 3 AVTCompletedNo Results AvailableHeart Failure|Atrial FibrillationDevice: CONTAK RENEWAL 3 AVThttps://ClinicalTrials.gov/show/NCT00158977
182964182964EASYTRAK 4 Steerable LV LeadCompletedNo Results AvailableHeart FailureDevice: EASYTRAK 4 STEERABLE LV leadhttps://ClinicalTrials.gov/show/NCT00158964
182965182965Device Evaluation of Contak Renewal 2and Easytrak 2 - DECREASE-HFCompletedNo Results AvailableCongestive Heart FailureDevice: CONTAK RENEWAL 2/4/4HE CRT-D|Device: EASYTRAK 2 Leadhttps://ClinicalTrials.gov/show/NCT00158951
182966182966Clinical Study of the EASYTRAK 3 Spiral Fixation Coronary Venous Bipolar Pace/Sense LeadCompletedNo Results AvailableCongestive Heart FailureDevice: EASYTRAK 3 left ventricular pacing leadhttps://ClinicalTrials.gov/show/NCT00158938
182967182967The EASYTRAK EPI Clinical InvestigationCompletedNo Results AvailableBradycardia|Congestive Heart FailureDevice: EASYTRAK EPI leadhttps://ClinicalTrials.gov/show/NCT00158925
182968182968VAST - Ventricular Arrhythmia Suppression TrialCompletedNo Results AvailableTachycardiaDevice: Implantable Cardioverter Defibrillatorhttps://ClinicalTrials.gov/show/NCT00158912
182969182969GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein CholesterolCompletedNo Results AvailableDyslipidaemias|DyslipidaemiaDrug: GW501516 oral tabletshttps://ClinicalTrials.gov/show/NCT00158899
182970182970Oral Topotecan As A Radiosensitizing Agent In Rectal CancerTerminatedNo Results AvailableRectal CancerDrug: Hycamtinhttps://ClinicalTrials.gov/show/NCT00158886

* Görseller ve İçerik tekif hakkına sahip olabilir